Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01851603 · ClinicalTrials.gov registry record · Phase 1
Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects
A Phase 1 study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01851603 is a Phase 1 study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 12 participants.
The verdict
NCT01851603, a Phase 1 study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a brief inpatient study to determine the safety of a new drug in healthy people.
Interventions
- DRUG Placebo
- DEVICE AVL-3288
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01851603
The ClinicalTrials.gov registry entry for NCT01851603 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01851603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01851603 about?
NCT01851603 is a clinical study titled "Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects". This is a brief inpatient study to determine the safety of a new drug in healthy people.
What is the current status of trial NCT01851603?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2013-06. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01851603?
The interventions under investigation include: Placebo (DRUG), AVL-3288 (DEVICE).
Who is sponsoring clinical trial NCT01851603?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.